Global Human Rabies Vaccines Market Insights and Forecast to 2027

Rabies vaccine is a vaccine used to prevent rabies.They can be used to prevent rabies before and for a period of time after exposure to the virus such as by a dog or bat bite.The immunity that develops is long lasting after a full course.
Global human rabies vaccines market is expected to witness robust growth over the forecast period. Increasing global incidences of mortality due to rabies, growing issue of stray dogs in countries with low economic development, rising number of pets, lack of pet management services, low immunization rates in pets, and rising friendliness with pets are drivers estimated to boost growth of human rabies vaccine market.

Market Analysis and Insights: Global Human Rabies Vaccines Market
The global Human Rabies Vaccines market is valued at US$ XX million in 2019. The market size will reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026.

Global Human Rabies Vaccines Scope and Market Size
Human Rabies Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Human Rabies Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Vero Cell Rabies Vaccine
BHK
Chick Embryo Cell Rabies Vaccine
Others

Segment by Application
Pre-Exposure Prophylaxis
Post-Exposure Prophylaxis

By Company
Sanofi Pasteur，Inc.
Novartis Vaccines and Diagnostics Ltd.
Cadila Pharmaceuticals Ltd.
GlaxoSmithKline Biologicals
Merck＆Co Inc.
Wyeth pharmaceuticals
Berna Biotech Ltd.
Medimmune LLC

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia

Frequently Asked Questions